Please use this identifier to cite or link to this item:
https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/4404| Journal Title: | Real-world treatment patterns and clinical outcomes for patients with deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC). |
| Authors: | Wong, Vanessa Kim, Grace Loft, Matthew Lee, Belinda Wong, Rachel Chong, Geoffrey Jalali, Azim Sem Liew, Mun Rainey, Natalie Heather Burge, Matthew E. Hayes, Theresa Tebbutt, Niall C. McLaughlan, Sue-Anne Mandaliya, Hiren A. Sutherland, Sarah Wong, Shu Fen Hui-Su Lim, Stephanie Nott, Louise M. Saqib, Avesha Gibbs, Peter |
| SWH Author: | Hayes, Theresa |
| Keywords: | dMMR Deficient Mismatch Repair Cancer mCRC Colorectal Cancer Pembrolizumab Oncology |
| Issue Date: | 2026 |
| Publisher: | Journal of Clinical Oncology |
| Date Accessioned: | 2026-06-21T23:26:09Z |
| Date Available: | 2026-06-21T23:26:09Z |
| Abstract: | The 5-year follow up results of KEYNOTE-177 established pembrolizumab as a standard first-line treatment for dMMR mCRC, demonstrating improved response rates, progression-free survival (PFS) and tolerability over chemotherapy. Pembrolizumab became widely available as a first-line option in Australia following government reimbursement in August 2021. Real world treatment patterns and outcomes have not been reported. |
| URI: | https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/4404 |
| Type: | Conference Paper |
| Conference Name: | 2026 ASCO Annual Meeting |
| Appears in Collections: | SWH Staff Publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| wong-et-al-2026-real-world-treatment-patterns-and-clinical-outcomes-for-patients-with-deficient-mismatch-repair-(dmmr).pdf | 53.56 kB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
